By Abionic
PSP is measured exclusively on the abioSCOPE Pancreatic Stone Protein (PSP) has emerged as a promising biomarker for sepsis diagnosis and outcome prediction 4. PSP, secreted by the pancreas, plays a crucial role in the neutrophil response during sepsis 5. PSP runs exclusively on the abioSCOPE®, an award-winning rapid diagnostics platform that leverages nanofluidics to deliver lab-quality results from a drop of blood in 7 minutes. Seamlessly integrated into routine clinical workflows, the test delivers fast, accurate, and user-friendly results in critical care settings. By measuring PSP levels, which are directly linked to a patient’s risk of sepsis, the test enables healthcare professionals to activate sepsis bundles earlier and improve outcomes. PSP levels increase earlier in the infection process than traditional biomarkers, offering the potential for earlier sepsis detection. Research shows that PSP levels can rise up to 3 days before clinical diagnosis 6. This early detection is especially beneficial in EDs, where PSP aids in early diagnosis, reducing unnecessary antibiotic use and supporting stewardship strategies 7. Its diagnostic potential has been validated in emergency departments (EDs) and intensive care units (ICUs) 8. PSP also serves as a reliable prognostic marker for ICU mortality, outperforming CRP and matching PCT in predictive power 9. Its use in assessing severity and predicting mortality in septic patients allows for better resource allocation and patient stabilization. A key advantage of PSP is the availability of near-patient tests, which enable rapid, cost-effective bedside measurements within minutes 10. This quick turnaround is vital in high-stakes environments such as ED and ICU. Advantages EARLIER DETECTION OF SEPSIS PSP level rises up to 3 days before clinical recognition enabling faster intervention and improved outcomes. RELIABLE PROGNOSTIC VALUE Higher performances to current Standard of Care in predicting ICU mortality, enabling clinicians to better evaluate disease severity. RAPID NEAR PATIENT TESTING PSP is exclusively measured on the abioSCOPE ® platform, delivering lab-quality results within minutes from a drop of blood.
